Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
S&P Biotech SPDR
(NY:
XBI
)
101.26
+0.35 (+0.35%)
Official Closing Price
Updated: 8:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about S&P Biotech SPDR
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Mirati Plays Catch-Up With Amgen, Gilead's 2nd Try With AIDS Drug, Cytokinetics' Adcom Test And More: Key Nov FDA Decisions For Biotech Investors
December 02, 2022
Food and Drug Administration decisions and advisory committee verdicts slated for November were mostly positive. New molecular entity approvals so far this year trail 2021’s tally by about 35%.
Via
Benzinga
Uncertainty Grips Markets-On A Clear Day Maybe You Can See A Week Ahead
November 28, 2022
Healthcare stocks are now favored by many strategists because of their defensive nature and focus on US markets.
Via
Talk Markets
The 10 Most Shorted ETFs: Which Sectors Saw Short Interest Increase?
November 22, 2022
Investors often short stocks to hedge positions against long positions or as a way to bet against a particular company. Benzinga provides a look at the most shorted stocks here.
Via
Benzinga
Choppy Days Lie Ahead So Why Fight The Fed?
October 10, 2022
We are in a bear market with choppy days over the next few months.
Via
Talk Markets
My 3 Top Biotech Stock Picks for 2023
November 22, 2022
Biotech stocks are set to shine in 2023.
Via
The Motley Fool
Stocks Drop On November 17 As The Dollar Moves Higher
November 17, 2022
Stocks dropped as the dollar pushed higher ahead of options expiration.
Via
Talk Markets
Why Emergent Bio Is Leading A Biotech Bloodbath — With Xenon Pharma Trailing
November 09, 2022
Biotech stocks were hammered Wednesday, including several that had good news.
Via
Investor's Business Daily
2 Healthcare Stocks Poised to Rocket Higher in the 4th Quarter
November 06, 2022
These two healthcare stocks could deliver market-crushing gains by year's end.
Via
The Motley Fool
What To Watch In The S&P Biotech ETF After Johnson & Johnson's $16.6B Abiomed Deal
November 01, 2022
As the exodus out of mega-cap technology stocks continues, investors and money managers are looking for other sectors to rotate into.
Via
Benzinga
Can Biotech Stocks Continue Rallying In This Bear Market?
October 31, 2022
Via
Talk Markets
This Beaten-Down ETF Is Still a Screaming Bear-Market Buy
October 21, 2022
Investors wanting to profit from a potential biotech sector bounce should love this exchange-traded fund.
Via
The Motley Fool
Steady As She Goes With Healthcare Stocks
October 17, 2022
Favorable seasonality lies ahead for Q4 with a caveat of Q3 earnings reports.
Via
Talk Markets
My 3 Biggest Stock Market Predictions for October
October 11, 2022
Now's not the best time to bet the farm on anything other than more uncertainty coming up.
Via
The Motley Fool
Stocks May Be Nearing A Breaking Point
September 27, 2022
We are seeing high yield spreads widen, and looking at the ratio of the SHY to HYG; it is clear that we surpassed the June highs.
Via
Talk Markets
Can Healthcare Stocks Continue To Outperform?
September 26, 2022
Large-cap healthcare and biotech stocks have been resilient amidst the market turmoil caused by rising rates and the global geopolitical crisis.
Via
Talk Markets
Rare Economic/Technical Signal Has Only Flashed 9 Times In Last 54 Years
September 24, 2022
A rare stock market signal combining technical and economic data was recently flashed. What can we learn from history regarding stock market/recession probabilities?
Via
Talk Markets
3 Biotech Stocks to Buy Now for Extraordinary Gains
September 20, 2022
These biotech stocks should deliver big gains to long-term investors who purchase shares at a discount during the bear market.
Via
InvestorPlace
Here Are 10 Biotech Stocks — Including Catalyst And Viridian — That Would Have Netted You $10,000 More This Year
September 19, 2022
The biotech run off a June bottom is great — until you realize you could've netted more.
Via
Investor's Business Daily
The Three Best Anti-Aging Stocks to Buy in September
September 19, 2022
These three anti-aging stocks could see recovery ahead. ATHX, LCTX, and UBX can make great long-term investments
Via
InvestorPlace
Biotech Stocks Stand to Benefit as Biden Announces Support for Industry
September 12, 2022
President Biden has announced a new initiative to help U.S. biotech producers grow. Here's what this news means for biotech stocks.
Via
InvestorPlace
5 Monster Stock Market Predictions For The Week Of Sept. 12
September 11, 2022
This week will be interesting, with inflation data Tuesday and Wednesday. There will be a lot of Treasury auctions this week, which will move yields and stocks. The one wrinkle is that the VIX options...
Via
Talk Markets
Stocks Drop On August 6 As Financial Conditions Tightening More
September 06, 2022
Today’s battle for the S&P 500 was between 3,900 and 3,920. Right now, the index is just consolidating and is likely to drop to around 3,820 over the near term to fill the gap at that level.
Via
Talk Markets
REITs And Utilities Show Glimmer As The S&P Wilts
September 06, 2022
The S&P 500 failed to close below last Thursday's low as Utilities and REITs were bid.
Via
Talk Markets
Healthcare Sector Still Looks Good But Lacks Momentum
September 06, 2022
The summer rally is over it’s a holiday weekend with low trading volume and bad news is pervasive. A decent jobs report on Friday brought in buyers in early hours until Russia intervened with a Nord...
Via
Talk Markets
Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know
August 31, 2022
After August’s mixed tally for Food and Drug Administration approvals, investors turn to a new month, which has a fairly loaded calendar.
Via
Benzinga
Whither Small Caps After Fed’s Tough Talk?
August 29, 2022
For now its better not to “Fight the Fed” because they are fighting the with the market. Now that everyone is scared of the Fed's rhetoric it would be better to wait a week or so as more data and...
Via
Talk Markets
3 Investing Themes For The Next 3 Years
August 25, 2022
With all of the noise about Jackson Hole tomorrow and whether they will be hawkish, dovish, pivot or not, we wanted to take a step back and think about broad themes we are/will be pursuing over the...
Via
Talk Markets
“Wrong Side Of The Wave” Stock Market (And Sentiment Results)
August 17, 2022
Spreads peaked at 6% in early July and have now rolled over to 4.24% (176 bps) in the past 5 weeks alone. This looks more like a small “aftershock” than a new earthquake.
Via
Talk Markets
Check your Portfolio for Small Cap Weighting: Growth, Innovation or Speculation?
August 15, 2022
The SPDR S&P Biotech ETF remains our key indicator for small cap biotechs. It is up 14.55% over one month at $93.78 but is still down 16% YTD. The Russell 2000 is up 16.5% over one month mirroring...
Via
Talk Markets
Exploding Interest Rates May Finally Suck Stocks Lower
August 11, 2022
Stocks moved lower today, despite moving sharply higher to start.
Via
Talk Markets
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.